Comparisons
AOD-9604 Compared: Tesamorelin, Incretins, Secretagogues
AOD-9604 is an hGH fragment studied for lipolysis. How it differs from tesamorelin, sermorelin, CJC-1295, ipamorelin, MOTS-c and incretins.
Comparisons
AOD-9604 is an hGH fragment studied for lipolysis. How it differs from tesamorelin, sermorelin, CJC-1295, ipamorelin, MOTS-c and incretins.
Peptide Profiles
What sermorelin/ipamorelin and tesamorelin/CJC-1295/ipamorelin blends contain, how to calculate each component, molar ratios and how blends are tested.
Comparisons
Sermorelin, tesamorelin and CJC-1295 act on the GHRH receptor; ipamorelin and MK-677 on the ghrelin receptor. How the two classes differ and compare.
Comparisons
Tesamorelin keeps all 44 GHRH residues with an N-terminal cap; CJC-1295 shortens to 1-29 and substitutes four residues. How the two strategies compare.
Comparisons
Tesamorelin stimulates the pituitary, HGH is the hormone itself, IGF-1 LR3 acts downstream. How the three differ in feedback, size and research use.
Comparisons
Tesamorelin works through the GH axis; incretin peptides through GIP, GLP-1 and glucagon receptors; MOTS-c through AMPK. Four different mechanisms compared.
Comparisons
Tesamorelin activates the GHRH receptor; ipamorelin activates the ghrelin receptor. Structure, pharmacology, evidence base and why they are studied together.
Comparisons
Sermorelin is GHRH(1-29)-NH2; tesamorelin is full-length GHRH(1-44) with an N-terminal hexenoyl group. Structure, stability and clinical history compared.
Peptide Profiles
Tesamorelin is GHRH(1-44) with an N-terminal trans-3-hexenoyl group, the only GHRH analogue licensed for a specific indication. Structure, trials and handling.